Daptomycin-based aminoglycoside-sparing therapy for streptococcal endocarditis: a retrospective multicenter study.


Journal

Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 27 10 2020
medline: 18 1 2022
entrez: 26 10 2020
Statut: ppublish

Résumé

Streptococci still represent common etiologic agents of infective endocarditis (IE). Although renal failure is frequently reported as an aminoglycoside-associated adverse event, last international guidelines recommend a beta-lactam/gentamicin combination therapy. We retrospectively evaluated the use of daptomycin-based aminoglycoside-sparing combination therapy for the treatment of streptococcal IE in seven referral hospitals in Italy. Retrospective, multicenter, observational study. All patients with streptococcal IE admitted from 2016 to 2018 were enrolled. Mortality and incidence of acute kidney injury (AKI) were compared between Group A (standard of care, SoC) and Group B (daptomycin-based aminoglycoside-sparing combination therapy). Fifty-four patients were enrolled, 33 in Group A and 21 in Group B. Mortality was 2/33 (6%) in Group A and 0 in Group B (

Identifiants

pubmed: 33103614
doi: 10.1080/1120009X.2020.1838830
doi:

Substances chimiques

Aminoglycosides 0
Anti-Bacterial Agents 0
Gentamicins 0
beta-Lactams 0
Daptomycin NWQ5N31VKK

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-439

Auteurs

Carlo Pallotto (C)

Section of Infectious Diseases, Department of Medicine, University of Perugia, Perugia, Italy.
Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Central District, Tuscany Health Care, Bagno a Ripoli, Florence, Italy.

Francesco Sbrana (F)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Andrea Ripoli (A)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Tommaso Lupia (T)

Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy.

Silvia Corcione (S)

Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy.

Francesco Paciosi (F)

Section of Infectious Diseases, Department of Medicine, University of Perugia, Perugia, Italy.

Daniela Francisci (D)

Section of Infectious Diseases, Department of Medicine, University of Perugia, Perugia, Italy.

Maria Bruna Pasticci (MB)

Section of Infectious Diseases, Department of Medicine, University of Perugia, Perugia, Italy.

Emanuela Sozio (E)

Emergency Department, Spedali Riuniti of Livorno, North-West District, Tuscany Health Care, Livorno, Italy.

Giacomo Bertolino (G)

Pharmaceutical Department, ASSL Cagliari, Cagliari, Italy.

Novella Carannante (N)

First Division of Infectious Diseases, Cotugno Hospital, AORN dei Colli, Naples, Italy.

Carolina Rescigno (C)

First Division of Infectious Diseases, Cotugno Hospital, AORN dei Colli, Naples, Italy.

Antonio Carozza (A)

UOSD Advanced Techniques in Cardiosurgery, Monaldi Hospital, AORN dei Colli, Naples, Italy.

Giovanni Di Caprio (G)

Infectious Diseases Unit, AORN Sant'Anna e San Sebastiano, Caserta, Italy.

Eleonora Taddei (E)

Institute of Infectious Diseases, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.

Rita Murri (R)

Institute of Infectious Diseases, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.

Massimo Fantoni (M)

Institute of Infectious Diseases, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.

Michele Emdin (M)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Alberto Aimo (A)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Francesco Giuseppe De Rosa (FG)

Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy.

Carlo Tascini (C)

First Division of Infectious Diseases, Cotugno Hospital, AORN dei Colli, Naples, Italy.
SOC Infectious Diseases, Azienda Sanitaria Integrata del Friuli Centrale, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH